1,384 followers
AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models. by Shaw SM, Middleton J, Wigglesworth K, Charlemagne A…